Imperial College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes

Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships

We have 92 Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships

  • Pharmacy / Pharmaceutics×
  • clear all
Order by 
Showing 31 to 60 of 92
  Examining the longitudinal associations of polypharmacy and frailty with functional decline in older people with multimorbidity
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project, which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch and Dr Danijela Gnjidic at the University of Sydney.
  GW4 BioMed MRC DTP PhD studentship: Microneedle poration as a drug delivery technology to treat nail fungal infections: addressing an unmet medical need
  Dr B Delgado-Charro
Application Deadline: 25 November 2019

Funding Type

PhD Type

This project is one of a number that are in competition for funding from the ‘GW4 BioMed MRC Doctoral Training Partnership’ which is offering up to 18 studentships for entry in September 2020.
  GW4 BioMed MRC DTP PhD studentship: Structure of ART Toxins: understanding toxicity through host receptor interactions
  Prof R Mrsny, Dr G Masuyer
Application Deadline: 25 November 2019

Funding Type

PhD Type

This project is one of a number that are in competition for funding from the ‘GW4 BioMed MRC Doctoral Training Partnership’ which is offering up to 18 studentships for entry in September 2020.
  GW4 BioMed MRC DTP PhD studentship: Using artificial intelligence to identify risks to patient safety from poor quality medicines guidance for health professionals
  Dr M Jones
Application Deadline: 25 November 2019

Funding Type

PhD Type

This project is one of a number that are in competition for funding from the ‘GW4 BioMed MRC Doctoral Training Partnership’ which is offering up to 18 studentships for entry in September 2020.
  GW4 BioMed MRC DTP PhD studentship: Advances in clinical management and laboratory detection of synthetic cannabinoids (“Spice”)
  Dr T P Freeman
Application Deadline: 25 November 2019

Funding Type

PhD Type

This project is one of a number that are in competition for funding from the ‘GW4 BioMed MRC Doctoral Training Partnership’ which is offering up to 18 studentships for entry in September 2020.
  EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (LifETIME)

Funding Type

PhD Type

The CDT will train the next generation of leaders in developing in vitro tissues, sensing and diagnostics to develop humanised in vitro systems to drive better drug screening.
  Biodegradable composite materials (Bio-PolyMOFs) for applications in targeted delivery of drugs to improve healthcare and reduce antimicrobial resistance in developing countries and worldwide
  Research Group: Chemistry and Biosciences
  Dr S Nayak, Dr A L Kelly, Dr M Katsikogianni
Applications accepted all year round

Funding Type

PhD Type

Growing antimicrobial resistance (AMR) is one of the major global challenges and is linked to the use of unnecessarily high doses of orally administered antibiotics following medical surgery and infections.
  Formulation and evaluation of umbilical cord-derived mesenchymal stem cells exosomes and antioxidants, incorporated in nanoliposomes using microfluidics, for the treatment of solid tumours
  Research Group: Chemistry and Biosciences
  Dr M Najafzadeh, Prof D Anderson, Dr M Isreb
Applications accepted all year round

Funding Type

PhD Type

This project uses the Cord blood Stem Cells from healthy control and the white blood cells of blood cancer patients to investigate the efficacy and genotoxicity of different compounds in them by using various genetic endpoints.
  Ion channel gating kinetics and structure implication for drug delivery
  Research Group: Chemistry and Biosciences
  Dr L Shang, Dr Z Hughes
Applications accepted all year round

Funding Type

PhD Type

Ion channels are proteins which sit in the membrane of every cell in the body and control the flow of positively charged ions such as sodium and potassium into and out of the cell.
  Investigation of the impact of a student-centred pharmacy curriculum delivered predominantly by Team-Based Learning (TBL) Using a Mixed Methods Approach
  Research Group: Education Innovation Research and Development
  Dr S Jones, Dr S Twedell, Dr S McLean
Applications accepted all year round

Funding Type

PhD Type

Some would consider that there is a misalignment between educational practice and educational research with a high reliance of content delivery and less on information processing.
  Activity based proteomic probes for profiling CYP2W1 in cancer tissues
  Research Group: Institute of Cancer Therapeutics
  Dr C Sutton, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Cytochromes P450 (CYPs) are a superfamily of mixed function oxidases of which CYP1-4 subfamily members are unique in their ability to oxidise drugs.
  Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Prof P Loadman
Applications accepted all year round

Funding Type

PhD Type

Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis.
  Discovery of chemical and biological tools to probe hypoxic solid tumours
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Dr J Elies Gomez
Applications accepted all year round

Funding Type

PhD Type

A major challenge in cancer therapy is to develop therapeutic agents that selectively target tumour cells. One avenue towards the development of more selective cancer therapies is to exploit the unique physiological properties of solid tumours using prodrug approaches.
  Investigating the mechanism of action of dual antiangiogenic/ antineoplastic drugs using organotypic co-culture of fibroblasts and endothelial cells
  Research Group: Institute of Cancer Therapeutics
  Dr J Elies Gomez, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

An important feature of many types of cancer is the ability to develop abnormal angiogenesis (blood vessel formation); this allows cancer cells to gain access to nutrients and favours metastasis.
  New strategies in integrin antagonism
  Research Group: Institute of Cancer Therapeutics
  Dr H Sheldrake
Applications accepted all year round

Funding Type

PhD Type

The integrins are a family of transmembrane receptors which mediate cell-cell and cell-ECM adhesion, and signalling across the cell membrane involved in pathways controlling cell migration, proliferation, differentiation, cell survival and apoptosis.
  Pharmaceutical cocrystallisation for improved medicines
  Research Group: Medicines Development and Pharmaceutical Sciences
  Dr V Vangala, Prof A Paradkar
Applications accepted all year round

Funding Type

PhD Type

Active pharmaceutical ingredients (APIs) are frequently delivered to the patients in the solid-state formulation. Yet, therapeutic effectiveness of a dosage form depends on the bioavailability, stability and also on the manufacturability of the dosage form.
  Determining brain glycosylation in ageing and Alzheimer’s disease
  Research Group: Pharmacology and Experimental Therapeutics
  Dr R Williamson, Dr C Sutton
Applications accepted all year round

Funding Type

PhD Type

Increasing age is associated with lower levels of cognitive performance; concomitant with this is a decrease in brain glucose metabolism.
  ERK5 MAPK signalling in Alzheimer’s disease
  Research Group: Pharmacology and Experimental Therapeutics
  Dr J Muller, Dr S Kantamneni
Applications accepted all year round

Funding Type

PhD Type

Neurodegenerative diseases have devastating effects on individuals’ lives and our society, with no effective treatments available.
  Identifying glucose-dependent mechanisms underlying risk factors for Alzheimer’s disease
  Research Group: Pharmacology and Experimental Therapeutics
  Dr R Williamson, Dr S McLean
Applications accepted all year round

Funding Type

PhD Type

Several risk factors for Alzheimer’s disease including diabetes and midlife obesity are age-dependent and have an obvious metabolic component resulting in impaired glucose metabolism.
  Therapeutic resolution of Myodysplastic Syndrome (MDS)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.
  Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Prof C Wright
Applications accepted all year round

Funding Type

PhD Type

Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death.
  EPSRC Centre for Doctoral Training in Aerosol Science

Funding Type

PhD Type

The Centre for Doctoral training in Aerosol Science (CAS) is now recruiting to our 4-year PhD programme for 2019 entry.
  Development and Application of Novel PET Markers of Neuroinflammation
  Dr F Aigbirhio
Application Deadline: 3 December 2019

Funding Type

PhD Type

This project’s objective is to develop novel in vivo PET probes for application as sensitive markers of neuroinflammatory processes which are key components of several pathologies, including stroke, traumatic brain injury, multiple sclerosis and dementias.
  Evaluation of fungal complement evasion mechanisms via the lectin pathway
  Prof P Garred, Prof J Koehl
Application Deadline: 10 November 2019

Funding Type

PhD Type

The group of professor Peter Garred at the University of Copenhagen has deciphered the components of the lectin complement pathway.
  A human ’mini-gut-on-a-chip’ to study microbial-epithelial cell interactions (SAEEDU20DTP)
  Dr A Saeed, Dr M R Williams
Application Deadline: 25 November 2019

Funding Type

PhD Type

Human organoids are 3D fragments of adult tissues and ideally conserve all of the (stem) cell types and recapitulate all of the (patho)physiological processes associated with human health and disease.
  EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (LifETIME)

Funding Type

PhD Type

The CDT will train the next generation of leaders in developing in vitro tissues, sensing and diagnostics to develop humanised in vitro systems to drive better drug screening.
  FH, FHR and PTX-3 binding to opportunistic bacteria and malaria parasites
  Prof S Meri, Prof C Garlanda
Application Deadline: 10 November 2019

Funding Type

PhD Type

Infections pose a global threat because of spread of antibiotic resistance, hospital infections and problems in the third world. On the other hand, rapidly increasing information of microbial genomes now provides new opportunities to tackle virulence mechanisms of pathogenic microbes.
  Pupillometry as a Diagnostic & Prognostic Indicator in Neurological Diseases
  Prof R Chilcott
Application Deadline: 31 October 2019

Funding Type

PhD Type

Applications are invited for a University-funded PhD studentship to further develop an in-house prototype pupillometer for the detection of various neurological diseases.
  PhD studentship opportunity - Development of efficient aerosolization devices for formulated high viscosity inhalation products
  Prof D Murnane, Dr L Urbano
Application Deadline: 31 October 2019

Funding Type

PhD Type

The University invites applications to join our Hertfordshire Knowledge Exchange Partnership (HKEP) scheme, a 1-year industrial placement followed by a 3-year PhD studentship funded jointly by the European Regional Development Fund, Hertfordshire LEP and Merxin ltd.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.